| Literature DB >> 12566712 |
Nico Michel1, Peter Ohlschläger, Wolfram Osen, Eva-Jasmin Freyschmidt, Heidrun Guthöhrlein, Andreas M Kaufmann, Martin Müller, Lutz Gissmann.
Abstract
Successful vaccination against infections by high-risk papillomaviruses aiming at the prevention of cervical cancer most likely requires the induction of neutralizing antibodies and human papillomavirus (HPV)-specific T cells directed against early viral proteins such as E7. Whereas the technology for detection of antibodies is well established, measurement of T cells is more cumbersome and standardization of assays is difficult. By using chromium release assay, ELISPOT, tetramer staining and intracellular IFN-gamma assay, we compared the levels of HPV 16 E7-specific T cells obtained after immunization of C57BL/6 mice with different DNA expression vectors. We found that all four assays gave highly comparable results. ELISPOT can be recommended for future studies as it indicates the presence of activated (i.e. IFN-gamma-secreting) T cells in a quantitative manner and combines high sensitivity with relatively low T cell demand. Copyright 2002 S. Karger AG, BaselEntities:
Mesh:
Substances:
Year: 2002 PMID: 12566712 DOI: 10.1159/000067923
Source DB: PubMed Journal: Intervirology ISSN: 0300-5526 Impact factor: 1.763